Skip to Main Content

Paper Details

Matched cohort study of germline BRCA mutation carriers with triple negative breast cancer in brightness.
NPJ Breast Cancer
11
2021
BRCA, BRCA mutation, BRCA1/2, NAC, PARP, RNA, TNBC, carboplatin, carboplatinveliparib, gBRCA, gBRCA cancers, non-gBRCA cancers, patients, platinum, proliferation gene, triple negative breast cancer, triple-negative breast cancer, veliparib
Author NameAffiliation
Mark A WatsonWashington University School of Medicine
Lang LiThe Ohio State University
David Maag
William F SymmansUniversity of Texas, MD Anderson Cancer Center
  • 1 - 4

Datasets

Release 1.2